{"id":"W2754068533","doi":"10.1136/annrheumdis-2017-eular.5163","title":"AB0771 Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment in the liberate study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Apremilast; Medicine; Etanercept; Psoriasis; Dermatology; Placebo; Dermatology Life Quality Index; Psoriatic arthritis; Psoriasis Area and Severity Index; Clinical endpoint; Internal medicine; Mucocutaneous zone; Nail disease; Clinical trial; Surgery; Disease; Pathology; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001328805,0.0006118448,0.002105595,0.0002885817,0.0003422882,0.001171047,0.0004543913,0.0008911548,0.002285565],"category_scores_gemma":[0.001130661,0.0004098649,0.001579571,0.0003726407,0.0005368277,0.0009591655,0.0003147742,0.002318584,0.0006229387],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005294381,"about_ca_system_score_gemma":0.0005515463,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005083193,"about_ca_topic_score_gemma":0.001053521,"domain_scores_codex":[0.9993401,0.0002937316,0.00004023664,0.0001014444,0.00008693734,0.0001373988],"domain_scores_gemma":[0.9992313,0.0001802686,0.0001920892,0.00006376699,0.00005791445,0.0002745792],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8202563,0.006810397,0.04140354,0.0006489314,0.002830714,0.0003469934,0.0001691427,0.0009902008,0.01403804,0.0002464167,0.002863782,0.1093956],"study_design_scores_gemma":[0.4636341,0.2934558,0.2260654,0.0001968126,0.004056602,0.0009224162,0.0001733869,0.002030743,0.00335018,0.0003985313,0.005579458,0.0001365793],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925438,0.004710922,0.0001234675,0.0002876878,0.0000872555,0.0001160444,0.0005073027,0.00004218583,0.001581298],"genre_scores_gemma":[0.9960558,0.00133387,0.0002140913,0.000389812,0.000123257,0.00009612191,0.000715645,0.00001042389,0.001060966],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002285565,"threshold_uncertainty_score":0.007645965,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03525518595697935,"score_gpt":0.2823813366102179,"score_spread":0.2471261506532386,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}